Biopharmaceutical company
Active 2020–2021. The register lists this client once for every firm that files on its behalf; all 2 of its records are shown together here.
| Year | Firm | Period | Amount | Doc |
|---|---|---|---|---|
| 2021 | HOLLIS PUBLIC AFFAIRS |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Termination (No Activity) |
$10,000 | |
| 2021 | VAN SCOYOC ASSOCIATES |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Termination |
$40,000 | |
| 2021 | HOLLIS PUBLIC AFFAIRS |
3rd Quarter (July 1 - Sep 30) Registration |
— | |
| 2021 | VAN SCOYOC ASSOCIATES |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$50,000 | |
| 2021 | VAN SCOYOC ASSOCIATES |
1st Quarter (Jan 1 - Mar 31) 1st Quarter - Report |
$40,000 | |
| 2020 | VAN SCOYOC ASSOCIATES |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$50,000 | |
| 2020 | VAN SCOYOC ASSOCIATES |
3rd Quarter (July 1 - Sep 30) AMENDED |
$10,000 | |
| 2020 | VAN SCOYOC ASSOCIATES |
3rd Quarter (July 1 - Sep 30) AMENDED |
— | |
| 2020 | VAN SCOYOC ASSOCIATES |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$10,000 | |
| 2020 | VAN SCOYOC ASSOCIATES |
3rd Quarter (July 1 - Sep 30) Registration |
— |
| Firm | Filings | Amount |
|---|---|---|
| VAN SCOYOC ASSOCIATES | 8 | $190,000 |
| HOLLIS PUBLIC AFFAIRS | 2 | $10,000 |
| Issue | Activities |
|---|---|
| Health Issues | 9 |
| Medical/Disease Research/Clinical Labs | 8 |
| Manufacturing | 8 |
| Budget/Appropriations | 8 |